药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamethazine
Aluminium glycinate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Aluminium glycinate.
Sulfamethazine
Almasilate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Almasilate.
Sulfamethazine
Hydrotalcite
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Hydrotalcite.
Sulfamethazine
Aluminium acetoacetate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Aluminium acetoacetate.
Sulfamethazine
Magnesium silicate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magnesium silicate.
Sulfamethazine
Bismuth subnitrate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Bismuth subnitrate.
Sulfamethazine
Magaldrate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magaldrate.
Sulfamethazine
Calcium carbonate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Calcium carbonate.
Sulfamethazine
Aluminum hydroxide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Aluminum hydroxide.
Sulfamethazine
Oliceridine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Oliceridine.
Sulfamethazine
Benzhydrocodone
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Benzhydrocodone.
Sulfamethazine
Carfentanil, C-11
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Carfentanil, C-11.
Sulfamethazine
Tilidine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Tilidine.
Sulfamethazine
Phenazocine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Phenazocine.
Sulfamethazine
Phenoperidine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Phenoperidine.
Sulfamethazine
Meptazinol
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Meptazinol.
Sulfamethazine
Nicomorphine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Nicomorphine.
Sulfamethazine
Alphaprodine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Alphaprodine.
Sulfamethazine
Piritramide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Piritramide.
Sulfamethazine
Normethadone
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Normethadone.